NCT04730934

Brief Summary

In this study, the effects of the symptoms related to the diseases of patients with fibromyalgia during the COVID-19 pandemic, their limitations in their social and business life, the need for different drugs, stress levels and the effect of the pandemic on the disease activity will be evaluated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,360

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

January 28, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 29, 2021

Completed
27 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 25, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2021

Completed
Last Updated

March 1, 2021

Status Verified

February 1, 2021

Enrollment Period

2 months

First QC Date

January 28, 2021

Last Update Submit

February 26, 2021

Conditions

Keywords

FibromyalgiaPandemicChronic Pain

Outcome Measures

Primary Outcomes (6)

  • Physical activity

    The physical activities of the participants were evaluated before and during the pandemic with the options "I do not have physical activity", "I do my daily work at home", "I do daily walks", "I exercise regularly".

    4 weeks

  • Occupation conditions

    Participants were questioned about their occupational status before and during the pandemic as "I am a housewife", "I quit my job", "I worked from home", "I worked part-time" and "there was no change in my job".

    4 weeks

  • General health condition

    Participants were questioned that their health conditions before and during the pandemic were "much worse", "worse", "a little bad", "no change", "a little good" " better", It was questioned as "much better".

    4 weeks

  • General pain condition

    Participants were questioned that their pain conditions before and during the pandemic were "much worse", "worse", "a little bad", "no change", "a little good", " better", It was questioned as "much better".

    4 weeks

  • Perceived stress scale

    Participants were questioned that their stress conditions before and during the pandemic

    4 weeks

  • Fibromyalgia impact questionnaire

    Fibromyalgia patients were questioned with fibromyalgia impact questionnaire before and during the pandemic

    4 weeks

Study Arms (3)

Healthy population

Healthy individuals aged between 18-65

Other: Perceived stress scaleOther: The drugs used before and during the pandemic, the patient's job status, physical activity conditions, pain status

Chronic Low Back Pain Group

Patients aged between 18 and 65 and has at least 3 months of low back pain which started before pandemic.

Other: Perceived stress scaleOther: The drugs used before and during the pandemic, the patient's job status, physical activity conditions, pain status

Fibromyalgia Group

Patients aged between 18 and 65 and has a diagnosis of fibromyalgia for at least 6 months

Other: Perceived stress scaleOther: Fibromyalgia impact questionnaireOther: The drugs used before and during the pandemic, the patient's job status, physical activity conditions, pain status

Interventions

Perceived stress scale (PSS) : The PSS is a validated 10-item self-report questionnaire which asks individuals to indicate how often they have found their lives unpredictable, uncontrollable, and overloaded in the last month. The higher scores indicating greater perceived stress.

Chronic Low Back Pain GroupFibromyalgia GroupHealthy population

Fibromyalgia impact questionnaire (FIQ): The FIQ is composed of 10 items. The first item contains 11 questions related to physical functioning - each question is rated on a 4 point Likert type scale. Items 2 and 3 ask the patient to mark the number of days they felt well and the number of days they were unable to work (including housework) because of fibromyalgia symptoms. Items 4 through 10 are horizontal linear scales marked in 10 increments on which the patient rates work difficulty, pain, fatigue, morning tiredness, stiffness, anxiety and depression.

Fibromyalgia Group

Drug using: Antidepressant, SNRI, gabapentin, SSRI, myorelaxan, nsaid, paracetamol, pregabalin, tramadol, food supplement. Job status: Participants were questioned about their occupational status before and during the pandemic as "I am a housewife", "I quit my job", "I worked from home", "I worked part-time" and "there was no change in my job". Physical activity: "I do not have physical activity", "I do my daily work at home", "I do daily walks", "I exercise regularly". Pain status: Participants were questioned that their pain conditions before and during the pandemic were "much worse", "worse", "a little bad", "no change", "a little good", " better", It was questioned as "much better".

Chronic Low Back Pain GroupFibromyalgia GroupHealthy population

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

465 healthy participants, 465 patients with low back pain, 465 patients with fibromyalgia

You may qualify if:

  • patients aged between 18 and 65 years
  • patients who have low back pain lasting at least 3 months and started before pandemic
  • patients diagnosed with fibromyalgia for at least 6 months

You may not qualify if:

  • patients diagnosed with major depression
  • patients who have a history of back surgery, fracture, infection, spinal stenosis
  • patients with malignancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Çam and Sakura City Hospital

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

FibromyalgiaChronic Pain

Interventions

Perceived Stress Scale

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

January 28, 2021

First Posted

January 29, 2021

Study Start

January 1, 2021

Primary Completion

February 25, 2021

Study Completion

February 25, 2021

Last Updated

March 1, 2021

Record last verified: 2021-02

Locations